Mechanisms of translational control in dendrites

Neurobiology of Aging

Volumn 24, Issue 8, 2003, Pages 1105-1111

  Glanzer, Jason G ^a   Eberwine, James H ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer; APRA; Dendrites; IRES; mRNA transfection; mTOR; Parkinson; Rapamycin; Synaptic plasticity; Translation

Indexed keywords

AMYLOID BETA PROTEIN; CONNEXIN 32; FRAGILE X MENTAL RETARDATION PROTEIN; HAMARTIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NERVE PROTEIN; PROTEIN; PROTEIN DERIVATIVE; TUBERIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL; BIOSYNTHESIS; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CONFERENCE PAPER; CORRELATION ANALYSIS; DENDRITE; DENDRITIC SPINE; FRAGILE X SYNDROME; GENE DISRUPTION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTERNAL RIBOSOME ENTRY SITE; METABOLISM; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RNA TRANSLATION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SYNAPTOGENESIS; TRANSLATION REGULATION; TUBEROUS SCLEROSIS;

EID: 0345276563     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.04.006     Document Type: Conference Paper

References (60)

1. Aakalu G., Smith W.B., Nguyen N., Jiang C., Schuman E.M. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron. 30(2):2001;489-502.
2. Arnstein H.R., Barwick C.W., Lange J.D., Thomas H.D. Control of protein synthesis by amino acid supply. The effect of asparagine deprivation on the translation of messenger RNA in reticulocyte lysates. FEBS Lett. 194(1):1986;146-150.
3. Bienkowska-Szewczyk K., Ehrenfeld E. An internal 5′-noncoding region required for translation of poliovirus RNA in vitro. J. Virol. 62(8):1988;3068-3072.
4. Bodian D.A. Suggestive relationship of nerve cell RNA with specific synaptic sites. Proc. Natl. Acad. Sci. U.S.A. 53:1965;418-425.
5. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A.et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107(4):2001;477-487.
6. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B.et al. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17(12):1997;4536-4544.
7. Chang J.W., Schumacher E., Coulter P.M. II, Vinters H.V., Watson J.B. Dendritic translocation of RC3/neurogranin mRNA in normal aging. J. Neuropathol. Exp. Neurol. 56(10):1997;1105-1118.
8. Chen Q.S., Wei W.Z., Shimahara T., Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77(3):2002;354-371.
9. Chiang P.W., Carpenter L.E., Hagerman P.J. The 5′-untranslated region of the FMR1 message facilitates translation by internal ribosome entry. J. Biol. Chem. 276(41):2001;37916-37921.
10. Costa E., Auta J., Grayson D.R., Matsumoto K., Pappas G.D., Zhang X.et al. GABA(A) receptors and benzodiazepines: a role for dendritic resident subunit mRNAs(1). Neuropharmacology. 43(6):2002;925-937.
11. Creancier L., Morello D., Mercier P., Prats A.C. Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J. Cell Biol. 150(1):2000;275-281.
12. Crino P.B., Eberwine J. Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis. Neuron. 17(6):1996;1173-1187.
13. Dyer J.R., Michel S., Lee W., Castellucci V.F., Wayne N.L., Sossin W.S. An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation. Nat. Neurosci. 6(3):2003;219-220.
14. Eberwine J., Miyashiro K., Kacharmina J.E., Job C. Local translation of classes of mRNAs that are targeted to neuronal dendrites. Proc. Natl. Acad. Sci. U.S.A. 98(13):2001;7080-7085.
15. Fahmy L.H., Leader D.P. Insulin regulates the translation of rat skeletal-muscle messenger ribonucleic acid. Biochem. Soc. Trans. 6(4):1978;751.
16. Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17(5):1997;1539-1547.
17. Gutmann D.H., Zhang Y., Hasbani M.J., Goldberg M.P., Plank T.L., Petri Henske E. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Acta Neuropathol. (Berl.). 99(3):2000;223-230.
18. Holcik M., Korneluk R.G. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol. Cell Biol. 20(13):2000;4648-4657.
19. Hudder A., Werner R. Analysis of a Charcot-Marie-Tooth disease mutation reveals an essential internal ribosome entry site element in the connexin-32 gene. J. Biol. Chem. 275(44):2000;34586-34591.
20. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F.et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57(4):1998;334-337.
21. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P.et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet. 98(2):2001;161-167.
22. Jefferies H.B., Reinhard C., Kozma S.C., Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. U.S.A. 91(10):1994;4441-4445.
23. Jopling C.L., Willis A.E. N-myc translation is initiated via an internal ribosome entry segment that displays enhanced activity in neuronal cells. Oncogene. 20(21):2001;2664-2670.
24. Kacharmina J.E., Job C., Crino P., Eberwine J. Stimulation of glutamate receptor protein synthesis and membrane insertion within isolated neuronal dendrites. Proc. Natl. Acad. Sci. U.S.A. 97(21):2000;11545-11550.
25. Kiebler M.A., Hemraj I., Verkade P., Kohrmann M., Fortes P., Marion R.M.et al. The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: implications for its involvement in mRNA transport. J. Neurosci. 19(1):1999;288-297.
26. Kim Y.K., Back S.H., Rho J., Lee S.H., Jang S.K. La autoantigen enhances translation of BiP mRNA. Nucleic Acids Res. 29(24):2001;5009-5016.
27. Kozak M. Evaluation of the "scanning model" for initiation of protein synthesis in eucaryotes. Cell. 22(1 Pt 1):1980;7-8.
28. Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K., Copeland N.G.et al. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron. 14(2):1995;433-445.
29. Lyons W.E., George E.B., Dawson T.M., Steiner J.P., Snyder S.H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. U.S.A. 91(8):1994;3191-3195.
30. Mark M.D., Liu Y., Wong S.T., Hinds T.R., Storm D.R. Stimulation of neurite outgrowth in PC12 cells by EGF and KCl depolarization: a Ca(2+)-independent phenomenon. J. Cell Biol. 130(3):1995;701-710.
31. Mayford M., Baranes D., Podsypanina K., Kandel E.R. The 3′-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc. Natl. Acad. Sci. U.S.A. 93(23):1996;13250-13255.
32. Miller S., Yasuda M., Coats J.K., Jones Y., Martone M.E., Mayford M. Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron. 36(3):2002;507-519.
33. Miyashiro K., Dichter M., Eberwine J. On the nature and differential distribution of mRNAs in hippocampal neurites: implications for neuronal functioning. Proc. Natl. Acad. Sci. U.S.A. 91(23):1994;10800-10804.
34. Miyashiro K.Y., Beckel-Mitchener A., Purk T.P., Becker K.G., Barret T., Liu L.et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron. 37(3):2003;417-431.
35. Mohr E., Kachele I., Mullin C., Richter D. Rat vasopressin mRNA: a model system to characterize cis-acting elements and trans-acting factors involved in dendritic mRNA sorting. Prog. Brain Res. 139:2002;211-224.
36. Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M.et al. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett. 383(3):1996;219-222.
37. O'Donnell W.T., Warren S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25:2002;315-338.
38. Ohashi S., Koike K., Omori A., Ichinose S., Ohara S., Kobayashi S.et al. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 277(40):2002;37804- 37810.
39. Parker E.M., Monopoli A., Ongini E., Lozza G., Babij C.M. Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. Neuropharmacology. 39(10):2000;1913-1919.
40. Pestova T.V., Kolupaeva V.G., Lomakin I.B., Pilipenko E.V., Shatsky I.N., Agol V.I.et al. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. USA. 98(13):2001;7029-7036.
41. Pickering B.M., Mitchell S.A., Evans J.R., Willis A.E. Polypyrimidine tract binding protein and poly r(C) binding protein 1 interact with the BAG-1 IRES and stimulate its activity in vitro and in vivo. Nucleic Acids Res. 31(2):2003;639-646.
42. Pinkstaff J.K., Chappell S.A., Mauro V.P., Edelman G.M., Krushel L.A. Internal initiation of translation of five dendritically localized neuronal mRNAs. Proc. Natl. Acad Sci. USA. 98(5):2001;2770-2775.
43. Pyronnet S., Pradayrol L., Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol. Cell. 5(4):2000;607-616.
44. Raymond C.R., Redman S.J., Crouch M.F. The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons. Neuroscience. 109(3):2002;531-536.
45. Redpath N.T., Proud C.G. Molecular mechanisms in the control of translation by hormones and growth factors. Biochim. Biophys. Acta. 1220(2):1994;147-162.
46. Stanton P.K., Sarvey J.M. Blockade of long-term potentiation in rat hippocampal CA1 region by inhibitors of protein synthesis. J. Neurosci. 4(12):1984;3080-3088.
47. Steward O., Fass B. Polyribosomes associated with dendritic spines in the denervated dentate gyrus: evidence for local regulation of protein synthesis during reinnervation. Prog. Brain Res. 58:1983;131-136.
48. Steward O., Schuman E.M. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:2001;299-325.
49. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl. Acad Sci. USA. 99(1):2002;467-472.
50. Tee A.R., Fingar D.C., Manning B.D., Kwiatkowski D.J., Cantley L.C., Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad Sci. USA. 99(21):2002;13571-13576.
51. Trembleau A., Morales M., Bloom F.E. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence. J. Neurosci. 14(1):1994;39-53.
52. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64(1):1996;196-197.
53. Twiss J.L., Shooter E.M. Nerve growth factor promotes neurite regeneration in PC12 cells by translational control. J. Neurochem. 64(2):1995;550-557.
54. Van Gelder R.N., von Zastrow M.E., Yool A., Dement W.C., Barchas J.D., Eberwine J.H. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad Sci. USA. 87(5):1990;1663-1667.
55. Wanner I., Baader S.L., Oberdick J., Schilling K. Changing subcellular distribution and activity-dependent utilization of a dendritically localized mRNA in developing Purkinje cells. Mol. Cell Neurosci. 15(3):2000;275-287.
56. Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D., Miyashiro K.et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad Sci. USA. 94(10):1997;5395-5400.
57. Weiler I.J., Greenough W.T. Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. Am. J. Med. Genet. 83(4):1999;248-252.
58. Wirths O., Weickert S., Majtenyi K., Havas L., Kahle P.J., Okochi M.et al. Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques. Neuroreport. 11(17):2000;3737-3741.
59. Zhang H.T., Kacharmina J.E., Miyashiro K., Greene M.I., Eberwine J. Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution. Proc. Natl. Acad Sci. USA. 98(10):2001;5497-5502.
60. Zho W.M., You J.L., Huang C.C., Hsu K.S. The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus. J. Neurosci. 22(20):2002;8838-8849.